Investor Relations | CHUGAI PHARMACEUTICAL CO., LTD.

Skip To Voice Support Menu
For Body
For Menu
For Local Menu

Home > Investor Relations > Reports & Downloads > Presentation Materials

Jul 23, 2010: Information Meeting on FY 2010.12 2Q Financial Results

Aiming to Become a Top Japanese Pharmaceutical Company Review of Half Year 2010: Osamu Nagayama, President and CEO
FY2010 2Q Consolidated Financial Overview: Ryuzo Kodama, Executive Vice President and CFO
Overview of Development Pipeline: Tatsuro Kosaka, Executive Vice President,
Head of Lifecycle Management Marketing Unit.

Results for [All]

2010

Apr 23	1Q Results (Jan 10 - Mar 10) Conference Call 1Q Results (Jan 10 - Mar 10) Conference Call [306KB] Webcasts
Feb 04	Information Meeting on FY 2009.12 Financial Results Webcasts Information Meeting on FY 2009.12 Financial Results [716KB]

2009

Dec 07	Information Meeting on Diabetes Products Information Meeting on Diabetes Products [1MB]
Dec 01	Nomura Investment Forum 2009 Nomura Investment Forum 2009 [377KB]
Oct 27	3Q Results (Jan 09 - Sep 09) Conference Call FY2009 3Q Consolidated Financial Overview Overview of Development Pipeline [328KB]
Sep 30	Deutsche Bank Conference Deutsche Bank Conference [387KB]
Aug 26	Tour of Utsunomiya Plant Observation on Follow-on Biologics / Biosimilars [1.2MB]
Jul 24	Information Meeting on FY 2009.12 2Q Financial Results FY2009 2Q Consolidated Financial Overview [213KB] Overview of Development Pipeline [186KB]
Apr 24	1Q Results (Jan 09 - Mar 09) Conference Call FY2009 1Q Consolidated Financial Overview Overview of R&D Activities　 [297KB]
Mar 27	Information Meeting Aiming to Become a Top Japanese Pharmaceutical Company with Global-Level Capabilities [1.7MB]
Feb 05	Information Meeting on FY 2008.12 Financial Results FY2008 Consolidated Financial Overview [194KB] Overview of Development Pipeline [137KB]

2008

Oct 21	3Q Results (Jan 08 - Sep 08) Conference Call FY2008 3Q Consolidated Financial Overview [176KB]
Sep 02	Media Conference on Avastin Overview of Avastin and Assessment of its Proper Use in Japan [705KB] Progress in the Treatment of Metastatic Colorectal Cancer [993KB]
Aug 01	Information Meeting on 2008.12 Half-Year Financial Results FY2008 Interim Consolidated Financial Overview [203KB] Overview of R&D Activities [117KB]
May 22	Information Meeting on Actemra Product Overview of Actemra [779KB] Treatment evolution - from "alleviating & delaying" to "stopping" disease progression - [598KB]
Apr 22	1Q Results (Jan 08 - Mar 08) Conference Call FY2008 1Q Consolidated Financial Overview Overview of R&D Activities [185KB]
Mar 03	Media Conference on Herceptin Herceptin [986KB] Adjuvant Therapy with Trastuzumab [1.6MB] Pharmacoeconomics of Trastuzumab (Herceptin) [445KB]
Jan 31	Information Meeting on FY 2007.12 Financial Results New Mid-Term Business Plan "Sunrise 2012" [213KB] FY2007 Consolidated Financial Overview [213KB] Overview of R&D Activities [117KB]

2007

Dec 03	Nomura Investment Forum 2007 Chugai aims for further growth by leveraging change in the business environment [564KB]
Oct 23	3Q Results (Jan 07 - Sep 07) Conference Call FY2007 3Q Consolidated Financial Overview Overview of R&D Activities [165KB]
Sep 28	Deutsche Bank Conference Deutsche Bank Conference Overview of R&D Activities [299KB]
Sep 13	2007 Merrill Lynch Japan Conference Chugai's approach in a drastically changing business environment [1.1MB]
Aug 01	Information Meeting on 2007.12 Half-Year Financial Results FY2007 Interim Consolidated Financial Overview [275KB] Overview of R&D Activities [139KB]
Apr 23	1Q Results (Jan 07 - Mar 07) Conference Call FY2007 1Q Consolidated Financial Overview Overview of R&D Activities [187KB]
Feb 08	Information Meeting on FY 2006.12 Financial Results FY2006 Consolidated Financial Overview [197KB] Overview of R&D Activities [120KB]

2006

Oct 24	3Q Results (Jan 06 - Sep 06) Conference Call FY2006 3Q Consolidated Financial Overview Overview of R&D Activities [189KB]
Sep 22	Credit Suisse Seminar "Therapeutic Antibody" at Fuji-Gotemba Laboratories Therapeutic Antibody [1.3MB]
Sep 07	2006 Merrill Lynch Japan Conference R&D Activities [1.9MB]
Aug 01	Information Meeting on 2006.12 Half-Year Financial Results FY2006 Interim Consolidated Financial Overview [251KB] Overview of R&D Activities [123KB]
Apr 25	1Q Results (Jan 06 - Mar 06) Conference Call FY2006 1Q Consolidated Financial Overview Overview of R&D Activities [173KB]
Feb 10	Information Meeting on the New Mid-Term Business Plan and 2005 Financial Results Mid-Term Business Plan "Sunrise 2010" Challenge of "New 2010 Targets" [241KB] FY2005 Consolidated Financial Overview [280KB] Overview of R&D Activities [114KB] Tamiflu [159KB]

Earlier Presentation Materials

TSE Code:4519

(About 20 min delay)

Chart

To view PDF files,
you will need Adobe® Reader® which is available as a free download.